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Background
A large number of recent publications demonstrate the
effect of cell culture media on post-translational modifi-
cations of recombinant proteins [1]. In this study, aim-
ing to extend the toolbox of media design beyond the
commonly known media components, a large variety of
cell culture compatible chemical components such as
sugars in industrial relevant Chinese hamster ovary cell
lines (CHO) expressing recombinant antibodies were
identified and tested. One promising novel supplement
is presented hereafter.
Materials and methods
Fed-batch experiments in duplicates were conducted in
96-deepwell plates at a working volume of 450 µL in
each well. Before seeding the culture with either a
CHO-S or CHO-K1 cell line at 0.3·106 viable cells/mL
and 0.2·106 viable cells/mL, respectively, the cell culture
media was enriched with 0-50 mM of oligosaccharide.
Bolus feeds were added every two or three days. Viable
cell density was measured by Vi-CELLTM(Beckmann
Coulter) throughout the culture and at the end of the
culture at working day 14,product titer was determined
by Octet® (fortéBIO).The supernatants of each culture
were purified and N-glycan analysis was performed by
CGE-LIF technology (Life Technologies).
Results
Low and intermediate concentrations of the oligosac-
charide (0.1-10 mM) tended to increase the viable cell
density of the CHO-S cell cultures. At 30 mM and
50 mM of oligosaccharide cell growth was strongly
reduced. The peak cell density amounted to 4·106 viable
cells/mL while the control cultures reached 10·106
viable cells/mL. The CHO-K1 cell cultures exhibited
comparable cell growth with respect to the control up
to 30 mM of supplement. At 50 mM a slight decrease
of the viable cell density was observed. Both cell lines
yielded comparable amounts of recombinant antibody at
harvest on working day 14 up to 10 mM of supplement.
Beyond this concentration product titer decreased. At a
concentration of 50 mM, harvest product titer of CHO-
S cell cultures decreased to 61 % of the control culture
titer. CHO-K1 cultures showed a greater tolerance to
the oligosaccharide presence. Hence, the titer at 50 mM
still amounted to 76 % of the control.
Figure 1 presents the absolute percentage change in
glycosylation in function of the concentration of the
added concentration oligosaccharide in the culture med-
ium prior to inoculation. The glycosylation changes are
expressed in absolute percentages: % glycan(x mM sup-
plement) - % glycan(control) = absolute % change.
The abundance of galactosylated species slightly
decreased at supplement concentrations from 0.1 to
1 mM in both CHO-S and CHO-K1 cell cultures. At
higher concentrations, galactosylation was favored and
thus increased by 7.3 % (CHO-S), and respectively,
3.6 % (CHO-K1) at 50 mM. The increase of high man-
nose species (Man5, Man6 and Man7) correlated with
the supplement level in the medium of each culture. As
shown in Figure 1A, at low supplement concentrations
in CHO-S cell cultures, high mannose species increased
by 0.7 %,at 30 mM by 2.6 %, and at 50 mM by 3.9 %.
Figure 1B displays that with this approach a stronger
increase of high mannose species was obtained in CHO-
K1 cell cultures while limiting the impact on cell growth
even at the maximum tested supplement concentration.
Up to 5 mM, no substantial increase of high mannose spe-
cies was obtained. However, at 10 mM, with comparable
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viable cell density and titer with respect to the control, the
high mannose level was 1.7 % higher than the control. By
further raising the supplement concentration to 30 mM
and 50 mM, the generation of high mannose species
became more abundant. At 30 mM the increase amounted
to 5.9 % and at maximum concentration to 9.7 % with lim-
ited impact on cell growth and as described above a titer
reduction of about 25 %.
Figure 1 Absolute % change in glycosylation in function of carbon-source supplement concentration (0.1-50 mM) with respect to non-
supplemented control. (a) CHO-S cell culture. (b) CHO-K1 cell culture.
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As a consequence of the increase of high mannose
species, a fucosylated species increased and fucosylated
species decreased. No important impact on sialylated
and unknown glycan species was observed in our
experiments.
Conclusions
Our experimental data demonstrate the feasibility and
the great potential of protein quality engineering by cell
culture media design. Rather than modifying the gene
expression of the cell line, including knockout techni-
ques for changing the host cell type, media design is an
attractive alternative to modify the glycosylation profile
as it allows to rapidly tune the quality profile within the
cell’s potential. Media optimization is hence expected to
become a commonly used strategy to enhance the phar-
macological properties of tomorrows’ therapeutic
molecules.
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